Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about ProFrac Holding Corp. - 2025/08/12
$75.0 Million
Image
ProFrac Holding Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Compass Therapeutics LLC - 2025/08/14
$120.0 Million
Image
Compass Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Orchestra BioMed, Inc. - 2025/08/01
Image
Orchestra BioMed
Confidentially Marketed Follow-On Offering & PIPE
Active Bookrunner
Read more
about Milestone Pharmaceuticals Inc. - 2025/07/11
Image
Milestone Pharmaceuticals
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ABIVAX S.A. - 2025/07/23
$747.4 Million
Image
ABIVAX
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Nektar Therapeutics - 2025/06/30
$100.0 Million
Image
Nektar Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Inovio Pharmaceuticals, Inc. - 2025/07/02
$25.0 Million
Image
Inovio Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Orange County Bancorp, Inc. - 025/06/03
$45.9 Million
Image
Orange County Bancorp, Inc.
Follow-On Common Stock Offering
Lead Bookrunner
Read more
about Birkenstock Holding plc - 2025/05/30
$845.2 Million
Image
Birkenstock Holding
Confidentially Marketed Follow-On Offering
Co-Manager
Read more
about Akebia Therapeutics, Inc. - 2025/03/19
$50.0 Million
Image
Akebia Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 2
Next page
››
Subscribe to CMFO